Table 3.
Overall survival analyses of the patients with extensive disease small cell lung cancer (n=186)
| Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P-value | HR | 95% CI | P-value | |
| Age, ≥75 vs <75 years | 1.41 | 0.98–2.02 | 0.064 | |||
| Sex, female vs male | 1.19 | 0.77–1.82 | 0.44 | |||
| Smoking status, former/current vs never | 1.47 | 0.55–3.97 | 0.45 | |||
| ECOG performance status, 2–4 vs 0–1 | 1.60 | 1.15–2.23 | 0.006 | 1.28 | 0.90–1.82 | 0.17 |
| Brain metastasis, yes vs no | 0.98 | 0.61–1.59 | 0.94 | |||
| Albumin, low vs normal | 1.84 | 1.32–2.55 | <0.001 | 1.40 | 0.99–1.99 | 0.060 |
| LDH, high vs normal | 2.00 | 1.37–2.89 | <0.001 | 1.73 | 1.18–2.54 | 0.005 |
| Sodium, low vs normal | 1.41 | 0.95–2.09 | 0.090 | |||
| Platinum-based chemotherapy, yes vs no | 0.73 | 0.53–1.01 | 0.058 | |||
| M descriptors, M0/1a/1b vs M1c | 2.21 | 1.58–3.09 | <0.001 | 1.95 | 1.38–2.77 | <0.001 |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase.